Pharmaceuticals

Erythropoietin (EPO) Market Outlook 2026–2030: Key Business Drivers and Trends

March 2, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the erythropoietin (epo) market from 2026–2035 with trusted insights from The Business Research Company

What growth pattern is forecast for the Erythropoietin (EPO) Market size between 2026 and 2035?

The erythropoietin (epo) market has seen substantial expansion in recent years. Its valuation is set to increase from $19.25 billion in 2025 to $21.46 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.5%. This market’s historical growth can be ascribed to the increasing occurrence of anemia, a rising incidence of chronic kidney disease, the well-established clinical efficacy of epo therapy, progress in recombinant biologic manufacturing, and the broader application of epo in managing anemia associated with cancer.

The erythropoietin (epo) market size is set to experience significant expansion in the upcoming years. It is forecast to reach $35.04 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 13.0%. This anticipated growth can be attributed to several factors including an increase in biosimilar approvals, a burgeoning elderly demographic, a rising number of dialysis patients globally, innovations in sustained-release epo drugs, and improved access to biologic therapies in emerging economies. Notable trends for the forecast period include the expanded application of erythropoietin in chronic kidney disease, a growing adoption of biosimilar erythropoietin treatments, an increasing demand for long-acting epo formulations, more frequent use of epo in oncology supportive care, and enhanced regulatory oversight concerning epo safety and dosage.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3436&type=smp

Which Drivers Are Impacting Market Performance In The Erythropoietin (EPO) Market?

The increasing prevalence of chronic kidney diseases is projected to boost the demand for the erythropoietin market in the coming years. The rising instances of chronic kidney disease necessitate the use of erythropoietin, which is vital for red blood cell production and immunity enhancement. For illustration, data from 2023 by the Centers for Disease Control, a US-based federal agency, indicates that around 14% of U.S. adults, translating to approximately 35.5 million people, are estimated to have chronic kidney disease (CKD). Thus, the escalating occurrence of chronic kidney diseases drives up the requirement for erythropoietin, thereby increasing market revenues.

What Segment Types Are Examined In The Erythropoietin (EPO) Market?

The erythropoietin (epo) market covered in this report is segmented –

1) By Product: Epoetin-alfa, Epoetin-beta, Darbepoetin-alfa, Other Products

2) By Drug Class: Biologist, Biosimilar

3) By Application: Cancer, Hematology, Renal Diseases, Neurology, Other Applications

Subsegments:

1) By Epoetin-Alfa: Epoetin-Alfa, Epoetin-Alfa Biosimilars

2) By Epoetin-Beta: Epoetin-Beta, Epoetin-Beta Biosimilars

3) By Darbepoetin-Alfa: Darbepoetin-Alfa, Darbepoetin-Alfa Biosimilars

4) By Other Products: Peginesatide, Novel EPO Products

What Trends Are Projected To Support The Growth Of The Erythropoietin (EPO) Market?

Leading companies in the erythropoietin market are concentrating on introducing oral medications that provide more convenient alternatives to traditional injectable treatments. This endeavor aims to enhance patient comfort, adherence, and flexibility in treatment, particularly for individuals dealing with chronic conditions like anemia in chronic kidney disease (CKD). For instance, in February 2023, GlaxoSmithKline (GSK), a UK-based multinational pharmaceutical and biotechnology firm, launched Jesduvroq (daprodustat) tablets. This oral medicine helps elevate erythropoietin levels, aiding in the management of anemia in CKD patients by maintaining hemoglobin levels within a specific range. The principal goal of Jesduvroq is to offer a more convenient option than injectable therapies, thereby improving patient comfort, compliance, and treatment flexibility for dialysis patients.

Who Are The Major Companies Operating In The Erythropoietin (EPO) Market?

Major companies operating in the erythropoietin (epo) market are Amgen Inc., Roche Holding AG, Pfizer Inc., Merck & Co., Teva Pharmaceutical Industries Ltd., 3SBio Inc., Celltrion Inc., Intas Pharmaceuticals Ltd., Boehringer Ingelheim GmbH, Dr. Reddy’s Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Reliance Life Sciences Pvt. Ltd., Biocon Limited, Chugai Pharmaceutical Co., Kyowa Kirin Co. Ltd., Apotex Inc., CJ Healthcare Corp., STADA Arzneimittel AG, Hospira Inc., Sandoz International GmbH, Torrent Pharmaceuticals Ltd., LG Life Sciences Ltd., Sanofi S.A., Bayer AG, Hikma Pharmaceuticals.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/erythropoietins-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Erythropoietin (EPO) Market?

North America was the largest region in the erythropoietin (EPO) market in 2025. The Middle East is expected to be the fastest growing region in the global erythropoietin (EPO) market analysis in the forecast period. The regions covered in the erythropoietin (epo) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Erythropoietin (EPO) Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=3436&type=smp

Browse Through More Reports Similar to the Global Erythropoietin (EPO) Market 2026, By The Business Research Company

Protein Expression Market Report 2026

https://www.thebusinessresearchcompany.com/report/protein-expression-global-market-report

Therapeutic Proteins Market Report 2026

https://www.thebusinessresearchcompany.com/report/therapeutic-proteins-global-market-report

Hematology Analyzers And Reagents Market Report 2026

https://www.thebusinessresearchcompany.com/report/hematology-analyzers-and-reagents-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795